Does low DHEA-S indicate reduced adrenal androgen output and worsen androgen availability and stress buffering when testosterone is low?

In aging men, the interplay between adrenal and testicular hormones is a critical determinant of metabolic and psychological resilience. Dehydroepiandrosterone sulfate (DHEA-S) serves as the primary reservoir for adrenal androgens, and its levels are essential for maintaining the total androgenic pool, particularly when primary testicular production begins to decline.

Adrenal Output and Biomarker Status

DHEA-S is the established gold-standard biomarker for the secretory capacity of the adrenal zona reticularis. Unlike other steroids, it has a long half-life and stable circulating levels, providing a reliable measure of adrenal androgenic function.

• Adrenopause: There is a well-documented decline in DHEA-S with age, with research showing a strong inverse correlation (r = -0.7) between age and DHEA-S levels in men.
• Diagnostic Sensitivity: Low DHEA-S exhibits high diagnostic sensitivity (80–87%) for detecting adrenal insufficiency and impaired hypothalamic-pituitary-adrenal (HPA) axis function.

Androgen Availability and Peripheral Conversion

While testicular production accounts for approximately 78% of free androgens in healthy young men, the remaining 22% is derived from adrenal precursors. In the context of low testicular testosterone, the importance of this adrenal contribution increases significantly.

• Intracrine Synthesis: DHEA-S acts as a precursor that peripheral tissues convert into potent androgens like testosterone and dihydrotestosterone (DHT) through enzymes such as 3β-hydroxysteroid dehydrogenase (3βHSD1).
• Compensatory Role: When testicular output is compromised (hypogonadism), the body relies more heavily on these adrenal pools to maintain tissue-specific androgen signaling. Consequently, low DHEA-S limits the substrate available for this secondary pathway, exacerbating total androgen deficiency.

Stress-Buffering and Cortisol Antagonism

DHEA-S functions as a primary "stress-buffer" by acting as a functional antagonist to cortisol, the body’s chief catabolic hormone.

• Antiglucocorticoid Mechanisms: DHEA-S modulates the enzyme 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1), which limits the conversion of inactive cortisone into active cortisol.
• Protection of Leydig Cells: In the presence of low testosterone, DHEA-S is vital for protecting remaining testicular function. It prevents cortisol from suppressing steroidogenic genes in Leydig cells, thereby preserving luteinizing hormone (LH) signaling and what remains of the androgen output.
• Resilience Ratio: A high DHEA-S to cortisol ratio is a recognized marker of psychological resilience and adaptive coping; conversely, a low ratio is associated with increased vulnerability to stress-induced physiological breakdown.

Bottom line

The evidence supports the claim that low DHEA-S reflects reduced adrenal output and significantly compromises overall androgen availability and stress resilience, particularly when testicular testosterone is low. This dual deficiency removes a critical backup system for androgenic activity and leaves the body more vulnerable to the catabolic effects of cortisol.